Zacks: Brokerages Expect Tivity Health Inc (TVTY) to Announce $0.32 EPS

Wall Street analysts forecast that Tivity Health Inc (NASDAQ:TVTY) will report earnings per share (EPS) of $0.32 for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Tivity Health’s earnings, with the lowest EPS estimate coming in at $0.31 and the highest estimate coming in at $0.34. Tivity Health posted earnings of $0.35 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 8.6%. The firm is scheduled to report its next earnings results after the market closes on Thursday, February 22nd.

According to Zacks, analysts expect that Tivity Health will report full year earnings of $1.61 per share for the current year, with EPS estimates ranging from $1.59 to $1.62. For the next fiscal year, analysts anticipate that the company will report earnings of $1.76 per share, with EPS estimates ranging from $1.67 to $2.14. Zacks’ EPS averages are an average based on a survey of research analysts that follow Tivity Health.

Several analysts have weighed in on the company. Zacks Investment Research raised Tivity Health from a “hold” rating to a “buy” rating and set a $44.00 price objective for the company in a report on Thursday, January 25th. BidaskClub cut Tivity Health from a “buy” rating to a “hold” rating in a report on Thursday, January 4th. Barrington Research reissued an “outperform” rating and set a $40.00 price objective (down from $46.00) on shares of Tivity Health in a report on Tuesday, November 7th. ValuEngine cut Tivity Health from a “buy” rating to a “hold” rating in a report on Monday, November 6th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $45.00 price objective on shares of Tivity Health in a report on Monday, November 6th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Tivity Health currently has an average rating of “Buy” and an average target price of $45.25.

Tivity Health (TVTY) opened at $36.20 on Friday. The stock has a market capitalization of $1,461.86, a PE ratio of 22.50, a P/E/G ratio of 1.91 and a beta of 0.25. Tivity Health has a twelve month low of $25.95 and a twelve month high of $48.50. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.02.

In other news, Director Conan Laughlin sold 115,087 shares of the company’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $33.87, for a total value of $3,897,996.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last ninety days, insiders sold 745,087 shares of company stock valued at $25,610,597. 8.42% of the stock is currently owned by company insiders.

Several hedge funds have recently made changes to their positions in TVTY. Neuberger Berman Group LLC increased its stake in shares of Tivity Health by 587.7% in the 3rd quarter. Neuberger Berman Group LLC now owns 1,633,016 shares of the company’s stock valued at $66,627,000 after acquiring an additional 1,395,539 shares during the last quarter. American Century Companies Inc. increased its stake in shares of Tivity Health by 390.7% in the 4th quarter. American Century Companies Inc. now owns 1,238,336 shares of the company’s stock valued at $45,261,000 after acquiring an additional 985,996 shares during the last quarter. Lord Abbett & CO. LLC increased its stake in shares of Tivity Health by 158.7% in the 2nd quarter. Lord Abbett & CO. LLC now owns 745,372 shares of the company’s stock valued at $29,704,000 after acquiring an additional 457,285 shares during the last quarter. American Capital Management Inc. increased its stake in shares of Tivity Health by 15.6% in the 4th quarter. American Capital Management Inc. now owns 1,072,823 shares of the company’s stock valued at $39,212,000 after acquiring an additional 144,995 shares during the last quarter. Finally, James Investment Research Inc. increased its stake in shares of Tivity Health by 11,202.1% in the 4th quarter. James Investment Research Inc. now owns 84,766 shares of the company’s stock valued at $3,098,000 after acquiring an additional 84,016 shares during the last quarter.

TRADEMARK VIOLATION NOTICE: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2018/02/09/zacks-brokerages-expect-tivity-health-inc-tvty-to-announce-0-32-eps.html.

Tivity Health Company Profile

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply